605077 Stock Overview
Zhejiang Huakang Pharmaceutical Co., Ltd. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
Zhejiang Huakang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥15.04 |
52 Week High | CN¥20.12 |
52 Week Low | CN¥11.85 |
Beta | 0.63 |
11 Month Change | -0.66% |
3 Month Change | 26.07% |
1 Year Change | -14.47% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -30.91% |
Recent News & Updates
Recent updates
Shareholder Returns
605077 | CN Food | CN Market | |
---|---|---|---|
7D | -2.6% | -3.5% | -2.1% |
1Y | -14.5% | -6.7% | 2.8% |
Return vs Industry: 605077 underperformed the CN Food industry which returned -6.7% over the past year.
Return vs Market: 605077 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
605077 volatility | |
---|---|
605077 Average Weekly Movement | 8.0% |
Food Industry Average Movement | 6.9% |
Market Average Movement | 8.4% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 605077 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 605077's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 1,350 | Deshui Chen | www.huakangpharma.com |
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers xylitol, a polyol with close to sugar sweetness; sorbitol, a sugar alcohol white crystal powder or colorless liquid; maltitol, a sugar alcohol; xylose that is used in xylitol production; and L-arabinos, which can be used as sucrose replacement or additives. The company was founded in 2001 and is based in Quzhou, China.
Zhejiang Huakang Pharmaceutical Co., Ltd. Fundamentals Summary
605077 fundamental statistics | |
---|---|
Market cap | CN¥4.48b |
Earnings (TTM) | CN¥283.61m |
Revenue (TTM) | CN¥2.85b |
15.8x
P/E Ratio1.6x
P/S RatioIs 605077 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
605077 income statement (TTM) | |
---|---|
Revenue | CN¥2.85b |
Cost of Revenue | CN¥2.23b |
Gross Profit | CN¥617.71m |
Other Expenses | CN¥334.10m |
Earnings | CN¥283.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.95 |
Gross Margin | 21.70% |
Net Profit Margin | 9.96% |
Debt/Equity Ratio | 66.1% |
How did 605077 perform over the long term?
See historical performance and comparison